|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 06, 2024 ) InsightAce Analytic, the "Bone Growth Stimulator Market in terms of revenue was estimated to be worth $1,161.47 Mn in 2023 and is poised to reach $1,967.46 Mn by 2031, growing at a CAGR of 7.04% from 2024 to 2031.
Download Free Demo Report: https://www.insightaceanalytic.com/request-sample/1443
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Bone Growth Stimulator Market are:
Increasing Incidence of Bone Fractures
Growing Aging Population
Preferential Shift to Non-Invasive Treatments
The following are the primary obstacles to the Bone Growth Stimulator Market's expansion:
Operational Costs
Limited Awareness
Reimbursement Issues
Future expansion opportunities for the global Bone Growth Stimulator Market include:
Technological Advancements
Expanding Applications
Rising Need for Home Healthcare
Market Analysis:
The bone growth stimulator market continues to exhibit robust growth driven by factors such as the rising incidence of bone fractures, an aging population, and ongoing technological advancements. Increasing preference for non-invasive treatments, coupled with a surge in orthopedic surgeries, has propelled the demand for these devices. However, challenges include the high cost of devices, limited awareness, and reimbursement issues. Opportunities lie in technological innovations, expanding applications, and collaborations. The market's trajectory is influenced by a shift toward home healthcare, personalized medicine, and the integration of telemedicine.
List of Prominent Players in the Bone Growth Stimulator Market:
Orthofix US LLC
Stryker
Medical Device Business Services, Inc.
Bioventus, Medtronic,
DJO, LLC
Zimmer Biomet
Arthrex, Inc.
Terumo Corporation,
Ossatec Benelux BV
Read Free Demo Overview: https://www.insightaceanalytic.com/report/global-bone-growth-stimulator-market/1443
Recent Developments:
In January 2022, Orthofix Medical Inc. (US) received FDA premarket approval for the AccelStim Bone Growth Stimulation Device.
In June 2022, Medtronic acquired Stimgenics to expand its portfolio in Differential Target Multiplexed Spinal Cord Stimulation Therapy.
In December In 2021. The company announced the competition of its spinoff of ZimVie. The spinoff marks a major milestone in Zimmer Biomet's active portfolio management.
Bone Growth Stimulator Market Dynamics:
Market Drivers:
Increasing Incidence of Bone Fractures The bone growth stimulator market is experiencing significant growth, largely propelled by the escalating incidence of bone fractures. Factors such as accidents, sports-related injuries, and the aging population contribute to the rising demand for bone growth stimulators. With an increasing number of individuals experiencing fractures, there is a heightened need for effective and efficient solutions to promote bone healing and fusion. As a result, bone growth stimulators, leveraging technologies like electrical stimulation and ultrasound, have become crucial in expediting the recovery process.
Challenges:
Reimbursement Issues Reimbursement issues pose a significant constraint on the bone growth stimulator market, hindering its widespread adoption. The high cost associated with bone growth stimulator devices, coupled with inadequate or inconsistent reimbursement policies in certain regions, limits accessibility for patients and healthcare facilities. The reliance on insurance coverage for medical expenses creates a barrier, impacting the affordability of these devices and potentially impeding their use. Addressing reimbursement challenges is crucial to unlocking the full potential of bone growth stimulators, ensuring that they reach a broader patient population and can be integrated more seamlessly into treatment protocols.
North America Is Expected To Grow With The Highest CAGR During The Forecast Period
The North America Bone Growth Stimulator Market is likely to register a significant revenue share and develop at a rapid CAGR in the near future. Several factors contribute to this growth, including the region's well-established healthcare infrastructure, increasing prevalence of bone-related disorders, and a growing aging population. The presence of key market players and ongoing technological advancements in medical devices further bolster the market's expansion in North America. Additionally, favorable reimbursement policies and a proactive approach to adopting innovative medical technologies contribute to the region's prominence in driving the growth of the bone growth stimulator market.
Segmentation of Bone Growth Stimulator Market-
By Product Type-
Bone Growth Stimulation Devices
Bone Morphogenetic Proteins
Platelet-rich Plasma
By Application-
Spinal Fusion Surgeries
Delayed Union & Non-Union Bone Fractures
Oral And Maxillofacial Surgeries
By End-Use-
Hospital & ASCs Home Care Settings
Academic & Research Institutions
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1443
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Insight Ace Analytics
Diana Dsouza
+8884144123
diana.dsouza@insightaceanalytics.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
